Compass Wealth Management LLC Makes New Investment in SPDR S&P Biotech ETF $XBI

Compass Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 11,499 shares of the exchange traded fund’s stock, valued at approximately $1,167,000.

A number of other institutional investors and hedge funds have also made changes to their positions in XBI. Capital A Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $26,000. DHJJ Financial Advisors Ltd. purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at about $25,000. Davis Capital Management purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $35,000. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $32,000. Finally, Johnson Financial Group Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $31,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $127.86 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $132.09. The stock has a market cap of $8.56 billion, a P/E ratio of 11.47 and a beta of 0.93. The stock’s 50 day simple moving average is $122.86 and its 200 day simple moving average is $106.29.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Recommended Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.